Oliver Barton Releases mTOR Atlas
The mTOR Atlas is a navigator for 322 works on the cellular system affected by rapamycin. Version 1.0.0 was released on August 22 and contains 45 topics, each with a model, intervention, and measured outcome to relate the publication to the question it answers.
The mTOR protein and signaling system, named after it, influences cell growth, protein synthesis, and autophagy through nutrient availability. Experiences in cell culture clarify the mechanism, experiences in animals test it in an organism, and human studies measure the outcome in humans. The Atlas index for each work preserves a link to the original publication, model, intervention, and outcome.
Two markings perform different functions: the pyramid shows how close the data stands to the outcome measured in humans, and levels A–D distinguish types of evidence. In the open upload, 29 level B works were conducted on humans, 84 level C works were conducted on animals, and 205 level D entries comprise mechanistic works and reviews. Such marking helps match the result with the conditions of the experience, as seen in fly experiments where the same dose of rapamycin on different diets changed the sign of the effect on lifespan.
One of the ten pages with open questions is dedicated to mTORC1 and mTORC2, two protein complexes of this system, and separates known results from a "justified hypothesis" about the rapamycin regimen that suppresses mTORC1 and spares mTORC2. To verify this, the Atlas suggests an experiment on mice: comparing lifespan, insulin sensitivity, and mTORC2 activity under different rapamycin regimens, as described in Nature Aging, July 2026.
🔗 Read original →